VHL腫瘍抑制器の折りたたみと品質管理は,明確なチャペロン経路を経由して行われます
Amie J McClellan1, Melissa D Scott, Judith Frydman
1Department of Biological Sciences and BioX Program, Stanford University, CA 94305, USA.
Cell
|June 7, 2005
まとめ
分子チャペロンは,タンパク質の運命をコントロールする. Hsp70およびHsp90を含む明確なチャペロン経路は,VHL腫瘍抑制体の折り畳みおよび退化を管理し,タンパク質品質管理の階層を明らかにします.
科学分野:
- 細胞生物学 細胞生物学
- 分子生物学は分子生物学である.
- タンパク質の折りたたみと分解
背景:
- 分子チャペロンによるタンパク質品質管理のメカニズムは完全に理解されていません.
- 細胞質タンパク質の品質管理は,細胞の健康にとって極めて重要です.
研究 の 目的:
- VHL腫瘍抑制器の折りたたみと退化のための明確なチャペロン要件を調査する.
- タンパク質トリアージの決定における特定のチャペロン経路の役割を明らかにする.
主な方法:
- 間違った折りたたまれたVHLの変数の折りたたみと劣化に対するチャペロン要件の分析.
- Hsp70,TRiC,Hsp90,およびHOP/Sti1p.の役割を調査しました.
主要な成果:
- 明確なチャペロン経路がVHLの折りたたみと劣化を制御する.
- TRiCはVHLの折りたたみには不可欠ですが,劣化にはなりません.
- Hsp90はVHLの劣化に不可欠ですが,折り畳みにはなりません.
- HOP/Sti1pは,HSP70とHSP90.0を橋渡しすることで,トリアージの決定を仲介することができます.
結論:
- 品質管理のためには独特のシャパロン・コンプレックスが必要である.
- チャペロンは,タンパク質のトリアージの決定に積極的に,特に参加します.
- 付き添いの相互作用の階層は,タンパク質の運命を制御する.
関連する概念動画
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.